New Indices for Predicting Glycaemic Variability

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Ogawa, Akifumi ^a   Hayashi, Akinori ^a   Kishihara, Eriko ^a   Yoshino, Sonomi ^a   Takeuchi, Akihiro ^a   Shichiri, Masayoshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; C PEPTIDE IMMUNOREACTIVITY; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MEDICAL PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE VALUES; ROC CURVE; SERUM ALBUMIN;

EID: 84866904153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046517     Document Type: Article

References (24)

1. The DECODE study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161: 397-405.
2. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, et al. (2006) Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 13: 555-561.
3. Buscemi S, Re A, Batsis JA, Arnone M, Mattina A, et al. (2010) Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med 27: 872-878.
4. Ceriello A, (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54: 1-7.
5. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, et al. (1976) Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 295: 417-420.
6. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, et al. (2002) Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 25: 275-278.
7. Kohnert KD, Augstein P, Heinke P, Zander E, Peterson K, et al. (2007) Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract 77: 420-426.
8. Tahara Y, Shima K, (1995) Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18: 440-447.
9. Kisugi R, Kouzuma T, Yamamoto T, Akizuki S, Miyamoto H, et al. (2007) Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin Chim Acta 382: 59-64.
10. Day JF, Thornburg RW, Thorpe SR, Baynes JW, (1979) Nonenzymatic glucosylation of rat albumin. Studies in vitro and in vivo. J Biol Chem 254: 9394-9400.
11. Suwa T, Ohta A, Matsui T, Koganei R, Kato H, et al. (2010) Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J 57: 135-140.
12. Koga M, Murai J, Saito H, Kasayama S, (2010) Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes. Diabetes Care 33: 270-272.
13. Kohnert KD, Augstein P, Zander E, Heinke P, Peterson K, et al. (2009) Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 32: 1058-1062.
14. Goto A, Takaichi M, Kishimoto M, Takahashi Y, Kajio H, et al. (2010) Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients. Endocr J 57: 237-244.
15. Saisho Y, Kou K, Tanaka K, Abe T, Kurosawa H, et al. (2011) Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes. Endocr J 58: 315-322.
16. Rodbard D, (2009) New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 11: 551-565.
17. Wojcicki JM, (1995) "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 27: 41-42.
18. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, et al. (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644-655.
19. Schlichtkrull J, Munck O, Jersild M, (1965) The M-Valve, an Index of Blood-Sugar Control in Diabetics. Acta medica Scandinavica 177: 95-102.
20. Service FJ, Nelson RL, (1980) Characteristics of glycemic stability. Diabetes Care 3: 58-62.
21. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ, (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 7: 253-263.
22. Weykamp C, John WG, Mosca A, (2009) A review of the challenge in measuring hemoglobin A1c. Journal of diabetes science and technology 3: 439-445.
23. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, et al. (2010) Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabet Int 1: 2-20.
24. Koga M, Murai J, Saito H, Kasayama S, Imagawa A, et al. (2010) Serum glycated albumin to haemoglobin A(1C) ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus. Annals of clinical biochemistry 47: 313-317.